The team will create 3,000 doses of the vaccine, which recognises the “red flag” proteins, known as neoantigens, and kills them.
British researchers are working to create the world’s first vaccine for lung cancer. It will work by using a strand of DNA that will train the immune system to seek and destroy “red flag” proteins that appear on lung cancer cells and can have potentially cancerous mutations inside. According to Sky News, the vaccine is being developed by scientists from the University of Oxford, the Francis Crick Institute and University College London (UCL). Called “LungVax”, it will be similar to the Oxford-AstraZeneca Covid vaccine, the outlet further said in its report.
The team will create 3,000 doses of the vaccine, which recognises the “red flag” proteins, known as neoantigens, and kills them, Lung cancer is the deadliest common cancer in Britain, with around 50,000 cases and 35,000 deaths every year.Seven in 10 cases are linked to smoking.High-risk people include those aged 55-74 who currently smoke, or have previously smoked.”Fewer than 10% of people with lung cancer survive their disease for 10 years or more. That must change,” Professor Mariam Jamal-Hanjani of UCL and the Francis Crick Institute, who will lead the LungVax clinical trial,
